These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 31401901)
21. Metallo-β-lactamase inhibitors: A continuing challenge for combating antibiotic resistance. Kang SJ; Kim DH; Lee BJ Biophys Chem; 2024 Jun; 309():107228. PubMed ID: 38552402 [TBL] [Abstract][Full Text] [Related]
22. The Development of New Small-Molecule Inhibitors Targeting Bacterial Metallo-β-lactamases. Wang P; Cheng J; Liu CC; Tang K; Xu F; Yu Z; Yu B; Chang J Curr Top Med Chem; 2018; 18(10):834-843. PubMed ID: 29773066 [TBL] [Abstract][Full Text] [Related]
24. Inhibitors for metallo-β-lactamases from the B1 and B3 subgroups provide an avenue to combat a major mechanism of antibiotic resistance. Kurz JL; Pedroso MM; Richard E; McGeary RP; Schenk G Bioorg Med Chem Lett; 2023 Aug; 92():129387. PubMed ID: 37369333 [TBL] [Abstract][Full Text] [Related]
25. Thiol-Containing Metallo-β-Lactamase Inhibitors Resensitize Resistant Gram-Negative Bacteria to Meropenem. Tehrani KHME; Martin NI ACS Infect Dis; 2017 Oct; 3(10):711-717. PubMed ID: 28820574 [TBL] [Abstract][Full Text] [Related]
26. Broad-Spectrum Inhibitors against Class A, B, and C Type β-Lactamases to Block the Hydrolysis against Antibiotics: Kinetics and Structural Characterization. Farhat N; Gupta D; Ali A; Kumar Y; Akhtar F; Kulanthaivel S; Mishra P; Khan F; Khan AU Microbiol Spectr; 2022 Oct; 10(5):e0045022. PubMed ID: 36069578 [TBL] [Abstract][Full Text] [Related]
28. Novel Cephalosporin Conjugates Display Potent and Selective Inhibition of Imipenemase-Type Metallo-β-Lactamases. Tehrani KHME; Wade N; Mashayekhi V; Brüchle NC; Jespers W; Voskuil K; Pesce D; van Haren MJ; van Westen GJP; Martin NI J Med Chem; 2021 Jul; 64(13):9141-9151. PubMed ID: 34182755 [TBL] [Abstract][Full Text] [Related]
29. Structural studies of triazole inhibitors with promising inhibitor effects against antibiotic resistance metallo-β-lactamases. Muhammad Z; Skagseth S; Boomgaren M; Akhter S; Fröhlich C; Ismael A; Christopeit T; Bayer A; Leiros HS Bioorg Med Chem; 2020 Aug; 28(15):115598. PubMed ID: 32631568 [TBL] [Abstract][Full Text] [Related]
30. Nitroxoline and its derivatives are potent inhibitors of metallo-β-lactamases. Proschak A; Martinelli G; Frank D; Rotter MJ; Brunst S; Weizel L; Burgers LD; Fürst R; Proschak E; Sosič I; Gobec S; Wichelhaus TA Eur J Med Chem; 2022 Jan; 228():113975. PubMed ID: 34865870 [TBL] [Abstract][Full Text] [Related]
31. Deciphering the Evolution of Cephalosporin Resistance to Ceftolozane-Tazobactam in Pseudomonas aeruginosa. Barnes MD; Taracila MA; Rutter JD; Bethel CR; Galdadas I; Hujer AM; Caselli E; Prati F; Dekker JP; Papp-Wallace KM; Haider S; Bonomo RA mBio; 2018 Dec; 9(6):. PubMed ID: 30538183 [No Abstract] [Full Text] [Related]
32. Design, Synthesis, and Biological Evaluation of New 1H-Imidazole-2-Carboxylic Acid Derivatives as Metallo-β-Lactamase Inhibitors. Li R; Su H; Chen W; Yan YH; Zhou C; Mou L; Yang H; Qian S; Wang Z; Yang L; Li GB Bioorg Med Chem; 2022 Oct; 72():116993. PubMed ID: 36084491 [TBL] [Abstract][Full Text] [Related]
33. VNRX-5133 (Taniborbactam), a Broad-Spectrum Inhibitor of Serine- and Metallo-β-Lactamases, Restores Activity of Cefepime in Hamrick JC; Docquier JD; Uehara T; Myers CL; Six DA; Chatwin CL; John KJ; Vernacchio SF; Cusick SM; Trout REL; Pozzi C; De Luca F; Benvenuti M; Mangani S; Liu B; Jackson RW; Moeck G; Xerri L; Burns CJ; Pevear DC; Daigle DM Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31871094 [TBL] [Abstract][Full Text] [Related]
34. Structure-guided optimization of D-captopril for discovery of potent NDM-1 inhibitors. Ma G; Wang S; Wu K; Zhang W; Ahmad A; Hao Q; Lei X; Zhang H Bioorg Med Chem; 2021 Jan; 29():115902. PubMed ID: 33302045 [TBL] [Abstract][Full Text] [Related]
35. Drug Repurposing of the Unithiol: Inhibition of Metallo-β-Lactamases for the Treatment of Carbapenem-Resistant Gram-Negative Bacterial Infections. Grigorenko VG; Khrenova MG; Andreeva IP; Rubtsova MY; Lev AI; Novikova TS; Detusheva EV; Fursova NK; Dyatlov IA; Egorov AM Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163756 [TBL] [Abstract][Full Text] [Related]
36. Challenges in the Development of a Thiol-Based Broad-Spectrum Inhibitor for Metallo-β-Lactamases. Büttner D; Kramer JS; Klingler FM; Wittmann SK; Hartmann MR; Kurz CG; Kohnhäuser D; Weizel L; Brüggerhoff A; Frank D; Steinhilber D; Wichelhaus TA; Pogoryelov D; Proschak E ACS Infect Dis; 2018 Mar; 4(3):360-372. PubMed ID: 29172434 [TBL] [Abstract][Full Text] [Related]
37. NOTA analogue: A first dithiocarbamate inhibitor of metallo-β-lactamases. Zhang E; Wang MM; Huang SC; Xu SM; Cui DY; Bo YL; Bai PY; Hua YG; Xiao CL; Qin S Bioorg Med Chem Lett; 2018 Jan; 28(2):214-221. PubMed ID: 29248295 [TBL] [Abstract][Full Text] [Related]
38. Metallo-β-lactamase inhibitory activity of 3-alkyloxy and 3-amino phthalic acid derivatives and their combination effect with carbapenem. Hiraiwa Y; Morinaka A; Fukushima T; Kudo T Bioorg Med Chem; 2013 Sep; 21(18):5841-50. PubMed ID: 23920484 [TBL] [Abstract][Full Text] [Related]
39. Understanding the binding conformation of ceftolozane/tazobactam with Metallo-β-lactamases VIM-5 and IMP-7 of Pseudomonas aeruginosa: A molecular docking and virtual screening process. Kullappan M; Mallavarapu Ambrose J; Surapaneni KM J Mol Recognit; 2021 Sep; 34(9):e2898. PubMed ID: 33780080 [TBL] [Abstract][Full Text] [Related]